Like your everyday actions, your charitable gifts have an impact on others.
Perhaps you have considered a charitable legacy to continue your philanthropy beyond your lifetime, to have your family remembered, and your philanthropy woven into the lives of others. With a legacy gift, you can.
We invite you to make your philanthropy endure through a planned gift to Open Medicine Foundation and join the Healthy Futures Society.
The Healthy Futures Society was established to recognize and thank those individuals who have identified Open Medicine Foundation as the best partner in the creation of a personal legacy through a planned gift. The Healthy Futures Society is our way of acknowledging their commitment to the future of Open Medicine Foundation today.
Gifts of all sizes are appreciated, and there are several ways to structure your gift.
Membership in the Healthy Futures Society serves as an example for others to follow, though if you prefer, we honor any requests for anonymity. Have you already added OMF to your estate plans? Please take a moment to inform us of your wishes, so that we can ensure your plans are honored.
The Healthy Futures Society Annual Meeting brings together members for a “State of the Foundation” presentation from CRC researchers.
With permission, Healthy Futures Society members are featured on Open Medicine Foundation’s website and highlighted in our Community Newsletter.
There are a variety of options for creating your charitable legacy, including ways to help you save on taxes and make your contributions go further.
Consider how these choices best fit your individual needs and goals:
Name Open Medicine Foundation as a beneficiary of your estate. Where there’s a will, there’s a way to honor your personal legacy of compassion.
Bequeath a specific dollar amount, an asset, a percentage, or the residue of your will or trust to Open Medicine Foundation. Because this portion of your estate is tax deductible, your donation may significantly reduce taxes otherwise payable by your estate.
Retirement Plans and Individual Retirement Accounts offer great tax benefits while you are living. However, at your death, the tax costs of these assets can be immense. One way to save your family and heirs the burden of these costs is to make a charitable contribution using these assets.
You may choose to designate Open Medicine Foundation as a beneficiary of your life insurance policy.
This charitable strategy pays the donor and named beneficiaries income now until the trust matures, when the remainder passes to Open Medicine Foundation. Cash, securities and appreciated real estate are transferred to the trust and a diversified investment portfolio is established to generate income for the donor. The donor receives an income tax deduction for a portion of the assets contributed to the trust and pays no capital gains tax on the transfer.
There are two types of Charitable Remainder Trusts
One of the most elegant ways to assure that your loved one’s name will be remembered is through a Named Gift to commemorate, memorialize or celebrate a family member or friend either in perpetuity, or over a fixed period of time.
Open Medicine Foundation offers opportunities to honor loved ones by affixing their names to grant programs, making them partners in a Healthy Future, for generations to come. Click here to learn more.
Open Medicine Foundation’s staff welcomes the opportunity to meet with you personally in order to understand and facilitate your wishes for the future. We also recommend discussing your wishes with an estate planner or other professional advisor.
To discuss adding Open Medicine Foundation to your estate plans, please contact Kathleen Morgen, Vice President of Philanthropy, email@example.com, 707-295-8007
Legal Name: Open Medicine Foundation
Tax ID: 26-4712664
29302 Laro Drive
Agoura Hills, CA 91301 USA
It is an estate planning best practice to include both the legal name and tax identification number in any will or trust documentation.
Averting a second pandemic:
Open Medicine Foundation leads groundbreaking international study of
Long COVID’s conversion to ME/CFS
AGOURA HILLS, CALIF. — Open Medicine Foundation (OMF) is leading a large-scale international collaborative study investigating the potential conversion of Post-Acute Sequelae SARS-CoV-2 infection — more commonly known as Long COVID or Post-COVID Syndrome — to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic, life-altering disease with no known cause, diagnostic test or FDA approved treatments available.
Up to 2.5 million people in the U.S. alone suffer from ME/CFS; the COVID-19 pandemic could at least double that number. An estimated 35 percent of Americans who had COVID-19 have failed to fully recover several months after infection, prompting many to call it “a potential second pandemic.”
OMF recognized a familiar health crisis emerging, one with eerie similarities to ME/CFS. This crisis presented a unique opportunity to understand how a viral infection — in this case COVID-19 — may develop into ME/CFS in some patients. The goal is to find targeted treatments for ME/CFS patients and ultimately prevent its onset in people infected with SARS-CoV-2 or other infections.
The federal government is only now investing in Post-COVID research, with no focus on its connection to ME/CFS. OMF has already engaged researchers for the largest-scale study of its kind, solely supported by private donors who have contributed over one million dollars to date. When fully funded, the five million dollar, three-year study will be conducted across the globe at OMF funded Collaborative Research Centers, led by some of the world’s top researchers and ME/CFS experts.
In a significant percentage of patients, infections preceded their development of ME/CFS. For example, according to the CDC about one in ten infected with Epstein-Barr virus, Ross River virus, or Coxiella burnetti develop symptoms that meet the criteria for ME/CFS.
The ability to follow the development of ME/CFS from a known viral infection is unprecedented to date and crucial to researchers’ understanding of the disease. The focus of this study is to find the biological differences between persons returning to good health after COVID-19 and persons who remained ill more than six months after infection and developed ME/CFS. Understanding these alterations in key pathways can lead to groundbreaking discoveries including new biomarkers, drug targets, and prevention and treatment strategies.
About Open Medicine Foundation
Established in 2012, Open Medicine Foundation leads the largest, concerted worldwide nonprofit effort to diagnose, treat, and prevent ME/CFS and related chronic, complex diseases such as Post Treatment Lyme Disease Syndrome, Fibromyalgia, and Post COVID. OMF adds urgency to the search for answers by driving transformational philanthropy into global research. We have raised over $28 Million from private donors and facilitated and funded the establishment of five prestigious ME/CFS Collaborative Research Centers around the world. To learn more, visit www.omf.ngo.
Heather Ah San
Development and Communications Manager